CRENESSITY
Live / Allowed — Notice of allowance issued (as of 18 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Jan 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99021893
- Mark type
- Design + words
- Filed
- 29 Jan 2025
- Published for opposition
- 23 Sept 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of adrenal insufficiency; pharmaceutical preparations for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
- Class 042 — Scientific and technological services: Providing medical research information; providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Scientific research in the nature of conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders, for others; conducting post-authorization pharmaceutical research for the marketing of pharmaceutical preparations and evaluating epidemiological results
- Class 044 — Medical, beauty and agricultural services: Providing medical information; Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 18 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Sept 2025 — PUBLISHED FOR OPPOSITION
- 17 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Jun 2025 — NOTIFICATION OF PRIORITY ACTION E-MAILED
- 09 Jun 2025 — PRIORITY ACTION E-MAILED
- 09 Jun 2025 — PRIORITY ACTION WRITTEN
- 04 Jun 2025 — ASSIGNED TO EXAMINER
- 22 May 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 22 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED